We have constructed an 8-base-pair insertion mutation in the 3' noncoding region of an infectious poliovirus cDNA clone that gives rise to a temperature-sensitive RNA synthesis mutant upon transfection into mammalian cells. The mutated cDNA was used to establish a cell line that releases the mutant poliovirus in a temperature-dependent fashion, representing a unique persistent viral infection. A poliovirus mutant mapping in the noncapsid region of the viral genome can be complemented in this cell line, implying that the cell line expresses viral proteins at the nonpermissive temperature.
The discovery that a cloned cDNA copy of the poliovirus RNA genome gives rise to infectious poliovirus upon transfection into mammalian cells (2, 3) opened up the possibility of constructing defined poliovirus mutants by mutagenizing the infectious cDNA. The opportunity to store the genetic information encoding a mutant poliovirus as a cDNA clone makes it possible to determine the nucleotide sequence of the mutated genome and to ensure that the mutation is responsible for the observed phenotype.
We report here the construction of several linker-insertion mutations in the 3' noncoding region ofthe viral genome. One of these mutations, PIH7387, gave rise to a temperaturesensitive poliovirus mutant. The infectious cDNA bearing this mutation was used to establish stable persistently infected human HeLa cell lines that release infectious poliovirus at the permissive temperature. Such cell lines, at the nonpermissive temperature, can complement another poliovirus mutant, showing that the integrated viral genome is translated.
MATERIALS AND METHODS
Cells and Viruses. HeLa cells were maintained in suspension culture in Joklik's modification of minimal essential medium (MEM) supplemented with 7% horse serum (GIBCO). CV1 cells were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10o fetal calf serum (Hazleton). Wild-type poliovirus was isolated from a single plaque derived from HeLa cells transfected with a pSV2-polio plasmid as described (2) . Protocols for preparation of virus stocks and viral infections have been described (4) .
Bacterial Strains and Plasmids. Escherichia coli strain HB101 was the host for all plasmids used and was obtained from C. Cepko (Harvard Medical School). Plasmid pSV2-polio was originally obtained from V. R. Racaniello (5) . The ligation mixture was transformed into HB101 and the recombinant pUC-polio was isolated using an alkaline minipreparation of bacterial cultures obtained from single bacterial colonies (6) . The pUC-polio plasmid was then digested with Taq I in the presence of ethidium bromide in order to increase the number of molecules containing only one double-stranded break (7) , and full-length linear molecules were isolated by low-melting agarose gel electrophoresis. Linear molecules (1 ,ug) were resuspended in 20 ,ul of 50 mM Tris HCl pH 7.6/50 mM NaCl/1 mM dithiothreitol/2 mM dNTPs. The single-stranded 5' termini were repaired by addition of 5 units of Klenow enzyme for 30 min at room temperature. The reaction was stopped by adding NaDodSO4 to a final concentration of 0.1%, followed by heating at 68°C for 5 min, phenol extraction, and precipitation with ethanol. The DNA molecules were either religated alone, to create 2-bp insertions, or after the addition of phosphorylated Hpa I or Xho I-linker oligomers (Collaborative Research, Waltham, MA) (5). Ligated molecules were transformed into HB101 and screened for recombinants that had either lost the targeted Taq I restriction endonuclease site or had acquired a new Hpa I or Xho I site at that position. The EcoRI/HindIII fragments of the pUC-polio subclones were prepared as described above and ligated with the 9028-bp HindIII/EcoRI DNA fragment prepared from the wild-type pSV2-polio plasmid. In this way, plasmids were obtained bearing a 2-bp insertion (PTF7387), Abbreviation: bp, base pair(s).
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. an 8-bp insertion (PTH7387), or a 10-bp insertion (PTX7387) at the Taq I restriction endonuclease site at nucleotide position 7387 of the viral genome. Predicted nucleotide sequence was verified by sequencing the 978-bp EcoRIl HindIII fragment (8) .
Construction ofPersistently Infected Cell Lines. Persistently infected HeLa cell lines were constructed by cotransfection of PTH7387 and pSV2-neo at a molar ratio of 20:1 using the calcium phosphate coprecipitation method (9) . At 4 hr after transfection, cells were shifted to 39.50C and maintained at this temperature. The drug G418 (GIBCO) was added to the medium 48 hr after transfection according to the protocol of Southern and Berg (10) . At 18 days after transfection, individual G418-resistant colonies were cloned and grown in duplicate at 39.50C and 320C. Of 136 cloned cell lines, 12 released PTH7387 at 320C within 3 days after the temperature shift. Representative persistently infected cell lines that were examined further were designated numbers 35 and 40. As a control cell line, we selected a G418-resistant line that does not contain poliovirus cDNA sequences, termed cell line 107.
RESULTS
Construction of Linker-Insertion Mutations in the Poliovirus cDNA 3' Noncoding Region. As part of a more general program of linker-insertion mutagenesis of an infectious poliovirus cDNA clone, we chose to insert linkers in Taq I sites near the 3' end of the viral genome ( Fig. 1) . The pSV2-polio plasmid, containing polio cDNA and a simian virus 40-derived promoter (11), has 17 Taq I sites, so we subcloned a 978-bp HindIII/EcoRI fragment into the unique HindIII and EcoRI sites of the plasmid pUC9 (12) . The pUC-polio plasmid contained five Taq I sites, one within the ampicillin-resistance gene, one in the 3' untranslated region of the cDNA, and three in coding sequences. The recombinant plasmid was partially digested with Taq I and full-length linear DNA molecules were isolated. These molecules, containing 2-bp 5' overhangs resulting from the Taq I digestion, were filled in at both ends with the Klenow fragment of DNA polymerase (5) and recircularized by ligation with DNA ligase, either immediately or after addition of DNA oligomers containing either 6-nucleotide bps of an Hpa I site or 8-nucleotide bps including an Xho I site. The plasmids containing insertions at the Taq I site in the 3' noncoding region (position 7387) were identified by restriction endonuclease digestions and their HindIII/EcoRI fragments were isolated and relegated to the largest fragment of a HindIII/EcoRI partial digest of the pSV2-polio plasmid. Recombinant full-length cDNA clones were obtained bearing 2-bp (PTF7387), 8-bp (PTH7387), or 10-bp (PTX7387) insertions in the 3' untranslated region at nucleotide position 7387 (Fig. 2) .
Phenotype of Poliovirus Mutants Mapping in the 3' Noncoding Region. Wild-type and linker-insertion-mutagenized pSV2-polio plasmids were transfected into HeLa cells by the DEAE-dextran transfection procedure (16) and were scored for the formation of poliovirus plaques at 32°C and 39.5°C. The cDNAs containing a 2-bp or a 10-bp insertion at position 7387 gave rise to plaques of wild-type size, and the yields of viruses were identical to wild-type at both temperatures. In contrast, the 8-bp Hpa I linker-containing cDNA (PTH7387) produced plaques only at 32°C. Virus stocks were prepared from such plaques and characterized for growth at both temperatures ( (Fig. 3B) , while line 107 did not. When the lines were infected with wild-type virus at 39.5°C, they produced equal numbers of large, quite homogeneous plaques (Fig. 3C) (Fig. 4A ), or producer cell line 40 (Fig. 4 B and C) , with the mutant HF121 or wild-type poliovirus. The infected cell lines were overlaid with agar and incubated at 39.50C for various lengths of time. The culture dishes were then stained with crystal violet and scored for plaques.
The HF121 mutant produced only very tiny plaques on cell line 107 (Fig. 4A) , as it does on uncloned HeLa cells. However, when plated on cell line 40, HF121 formed significantly larger plaques (Fig. 4B) Plaque assays were performed at the temperatures indicated and the virus titers are displayed as plaque-forming units of virus stock per ml.
size plaques (Fig. 4C) . We suggest that this increase in plaque size represents complementation of the HF121 mutant in cell line 40 . In another line that produces poliovirus after temperature downshift, cell line 35, HF121 also produced larger plaques.
Another possible explanation for the faster growth of HF121 in cell line 40 could be the formation of viral recombinants that overgrew the small plaque mutant viruses. To examine this possibility, we picked 20 plaques from the HF121-infected cell line 40 and assayed virus from each plaque on HeLa cells at 320C and 39.5°C. Virus from all 20 plaques displayed the mutant small-plaque phenotype at all temperatures (not shown). In addition, the titers at both temperatures were the same indicating that little or no endogenous viral RNA derived from pSVPTH7387 had been rescued.
In a different kind of complementation experiment, we tested the virus yield during single-cycle infections of cell lines 107 and 40. The yield and growth curve of wild-type virus was the same in both cell lines. Mutant HF121 grew more slowly in both cell lines, but its yield was 10 times higher from line 40 than from line 107 (Fig. 5) . Thus, cell line 40 apparently produces sufficient poliovirus products to complement at least one poliovirus mutant.
A . _. .iA~~~~~~~~~i n~~~~~A,,~~~~z, /~~~~~~r~D ISCUSSION We report here the construction of a poliovirus mutant mapping in the 3' noncoding region of the viral genome. The mutant was obtained by site-directed mutagenesis of an infectious cDNA clone using linker insertion at a known restriction endonuclease site. Having a cDNA copy of the mutation enabled us to perform "mix-and-match" experiments with DNA fragments bearing the desired mutation to unambiguously map the introduced mutation and the mutant phenotype to a single locus in the viral genome. Although we have not formally proven that the introduced mutation is present in the viral RNA genome, it is unlikely that other changes occur in the viral RNA molecule eliciting the mutant phenotype because every plaque isolate derived from the transfected mutated cDNA gives rise to the same temperature-sensitive mutant phenotype.
We chose the 65-nucleotide-long 3' noncoding region as a target for mutagenesis because it contains highly conserved sequences that might, for instance, be involved in the initiation of minus-strand RNA synthesis. Despite the fact that only three nucleotide changes (at positions 7405 and 7409) are found in this region among the three poliovirus strains (Fig. 2) (13) (14) (15) , nucleotide insertions at the Taq I site at position 7387 are tolerated. Mutants with 2-(PTF7387) or 10-(PTX7387) nucleotide insertions produced virus yields similar to wild-type virus, indicating that sequences 5' and 3' of this insertion need not be contiguous to provide their function. That an 8-nucleotide insertion at the same site gave rise to a conditional lethal mutant (PTH7387) is remarkable. Perhaps the RNA genome of PTH7387 folds properly at the permissive temperature but may contain a different secondary structure at the restrictive temperature and be unable to function. Temperature-dependent mutants of RNA molecules that affect the biological function of the nucleic acid have been described in tRNA (18, 19) and in mitochondrial rRNA (20, 21) .
The very strong temperature sensitivity of PTH7387 allowed us to produce a unique type of persistently infected cell. Persistently infected cells with poliovirus have been described (22) (23) (24) but were presumably based on slow replication of viral RNA rather than on storage of the genome as a DNA copy (25 nonretrovirus RNA viruses through a DNA copy has not been substantiated (26) . Retroviruses, of course, use the same strategy but are much more efficient in that they continually produce virus from all persistently-infected cells. Poliovirus, being lytic in its growth, and released by cell lysis, cannot both grow and be maintained in the same cell. Therefore, there may be selection against high expression during the establishment of the cell lines because poliovirus encodes powerful inhibitors of cellular protein synthesis and transcription, which might produce lethality at low levels. So far, we were unable to detect poliovirus-specific RNA in the persistently infected cells by RNA blot analysis (5) 
